Vitamin B12 and Folate in Non-dialysis Chronic Kidney Disease: A Cross-sectional Study from a Tertiary Care Centre
Background: Anaemia in non-dialysis chronic kidney disease (CKD) is multifactorial. In addition to erythropoietin deficiency, iron restriction and inflammation, nutritional deficiencies may contribute to ineffective erythropoiesis. Vitamin B12 and folate abnormalities may coexist with other causes of anaemia, but their pattern across CKD stages needs clearer description. Purpose/Objectives: To assess vitamin B12 and folate status in non-dialysis CKD patients and to study their relationship with CKD stage and anaemia patterns. Methods: This cross-sectional observational study was conducted at a tertiary hospital from April 2024 to September 2024. A total of 160 adults with non-dialysis CKD were enrolled. Inclusion criteria were age >18 years and estimated glomerular filtration rate <60 mL/min/1.73 m² for more than 3 months. Patients with acute infection or trauma, recent transfusion or parenteral iron, hemoglobinopathy, malignancy, overt blood loss, dialysis, post-transplant status, chronic infection, malabsorption, steroid therapy or erythropoiesis-stimulating agent therapy were excluded. Complete blood count, peripheral smear, renal function tests, iron studies, vitamin B12, folate, CRP, calcium, phosphorus, and PTH were assessed. Vitamin B12 and folate status were assessed according to the laboratory reference ranges. Vitamin B12 deficiency was defined as a serum vitamin B12 level <200 pg/mL, whilst folate deficiency was defined as a serum folate level <4.16 ng/mL. Data were analysed using SPSS version 24. Results: Mean age was 53.21 ± 10.76 years and 57.5% were male. CKD stages were G3a 5.6%, G3b 21.9%, G4 37.5% and G5 35.0%. Mean folate declined progressively from 14.91 ± 6.55 ng/mL in G3a to 9.35 ± 5.52 ng/mL in G5 (Kruskal–Wallis H = 10.013, P = .018). Vitamin B12 values were 207.71 ± 106.68, 282.75 ± 108.11, 274.06 ± 103.06, and 274.22 ± 102.45 pg/mL across G3a to G5, respectively (Kruskal–Wallis H = 3.864, P = .277). Anaemia was present in 93.7% of participants. ACD with B12 deficiency occurred in 16.9%, ACD with folate deficiency in 8.1%, and ACD with both B12 and folate deficiency in 1.3%. Conclusion: In this study of non-dialysis CKD patients, abnormalities of vitamin B12 and folate status were observed in association with anaemia, with folate levels showing a significant difference across CKD stages. These findings suggest that assessment of vitamin B12 and folate may be considered in selected patients with unexplained or mixed anaemia in CKD. However, given the cross-sectional design and single-centre setting of the study, these findings do not establish a clinical benefit of routine vitamin testing or supplementation. Further prospective studies are required to determine the clinical significance of these abnormalities and the potential benefit of targeted supplementation.
Authors
- Aftab Ahmed
- Jaisri Sathi
- Aswinikumar Aiyangar
Institutions
- Apollo Hospitals (IN)
Publication Details
- Journal
- Apollo Medicine
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1177/09760016261505632
- Primary Topic
- Folate and B Vitamins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00